Armata Pharmaceuticals, Inc.

ARMP · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,291$13,523$14,852$10,288
Short-Term Investments$0$0$0$0
Receivables$744$3,363$1,936$2,989
Inventory$0$0$0$0
Other Curr. Assets$1,273$2,265$10,259$1,718
Total Curr. Assets$11,308$19,151$27,047$14,995
Property Plant & Equip (Net)$54,928$57,276$46,652$38,072
Goodwill$3,490$3,490$3,490$3,490
Intangibles$10,256$10,256$10,256$10,256
Long-Term Investments$5,480$0$5,960$0
Tax Assets$0$0$12,043$0
Other NC Assets$975$8,190$2,429$2,955
Total NC Assets$75,129$79,212$80,830$54,773
Other Assets$0$0$0$0
Total Assets$86,437$98,363$107,877$69,768
Liabilities
Payables$766$1,585$6,034$1,138
Short-Term Debt$43,385$9,481$17,011$1,509
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,098$5,395$1,828$2,167
Total Curr. Liab.$48,249$16,461$24,873$4,814
LT Debt$83,130$110,890$31,804$36,480
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$3,077$3,077$15,120$3,077
Other NC Liab.$0$0$0$0
Total NC Liab.$86,207$113,967$46,924$39,557
Other Liabilities$0$0$0$0
Cap. Leases$32,125$38,064$31,804$37,989
Total Liabilities$134,456$130,428$71,797$44,371
Equity
Pref Stock$0$0$0$0
Common Stock$362$361$361$271
Retained Earnings-$327,735-$308,819-$239,774-$202,857
AOCI$0$0$0$0
Other Equity$279,354$276,393$275,493$227,983
Total Equity-$48,019-$32,065$36,080$25,397
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$86,437$98,363$107,877$69,768
Net Debt$117,224$106,848$33,963$27,701